2Ljungberg B,Jacobson SH,Lins LE,et al.Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly perneable polysulfone membrane[J].Clin Nephrol,1992,38(2):97-100.
3Moriniere P,Dieval J,Bayrou B,et al.Low-molecular-weight heparin Fraxiparin in chronic hemodialysis:a does finding study[J].Blood Purif,1989,7 (6):301-308.
4Council on Cardiovascular Disease in the Young;Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease;American Heart Association.Diagnostic guideline for Kawasaki disease[J].Circulation,2001,103(2):335 -336.
5Kher A,Samama MM.Primary and secondary prophylaxis of venous thromboembolism with low-melocular-weight heparins:Prolonged thromboprophylaxis,an alternative to vitamin K antagonists[J].J Thromb Haemost,2005,3 (3):473-481.
8Thanou M,Verhoef JC,Nihot MT,et al.Enhancement of the intestinal absorption of low molecular weight heparin (LMWH) in rats and pigs using carbopol 934P[J].Pharm Res,2001,18 (11):1638-1641.
9Matsagas MI.Outpatient treatment of venous thromboembolism using low molecular weight heparins[J].Int Angiol,2004,23 (4):305-316.
10Avritscher EB,Cantor SB,Shih YC,et al.Cost-minimization analysis of low-molecular-weight heparin (dalteparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis[J].Support Care Cancer,2004,12 (7):531-536.
